跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 306 条关于
“Visara”
全部
306
临床试验
217
药物
13
机构
29
资讯
47
10个月前
NovaBridge Subsidiary Visara Assigns VIS-101 License to Everest Medicines for Asian Markets
6个月前
NovaBridge's VIS-101 Shows Promising Phase 2a Results in Wet AMD with Potential Best-in-Class Durability
11个月前
I-Mab Announces Strategic Transformation to NovaBridge Biosciences with Hong Kong IPO Plans and VIS-101 Acquisition
上个月
NovaBridge to Report First Half 2026 Results and Corporate Update on August 20
去年
Cidara Therapeutics Regains CD388 for Universal Flu Prevention, Initiates Phase 2b Trial
去年
Lisata Therapeutics Advances Clinical Trials, Anticipates Data-Rich 2025
去年
Cidara Therapeutics Presents Positive Clinical Data on CD388 for Influenza Prevention
去年
Lisata Therapeutics Completes Enrollment in CENDIFOX Trial of Certepetide for Advanced Solid Tumors
2年前
Bicara Therapeutics and Zenas BioPharma Aim for $200 Million IPOs
2年前
Cidara Therapeutics Cuts Workforce to Prioritize CD388 Influenza Prevention Program
第 1 页,共 5 页
上一页
下一页